Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

T Parsons

Showing results (811-820 of 865) with videos related to

Pageof 87
Sort By:
Cancer Medicine|August 28, 2024
Atypical cancer risk profile in carriers of Italian founder BRCA1 variant p.His1673del: Implications for classification and clinical managementGiovanni Innella, Cristina Fortuno, Laura Caleca, et al.
NPJ Breast Cancer|September 30, 2025
Polygenic risk score for breast cancer risk prediction in Asian BRCA1 and BRCA2 pathogenic variants carriersMei-Chee Tai, Joe Dennis, Sue K Park, et al.
Human Mutation|July 12, 2019
Assessment of blind predictions of the clinical significance of BRCA1 and BRCA2 variantsMelissa S Cline, Giulia Babbi, Sandra Bonache, et al.
Conservation Biology : the Journal of the Society for Conservation Biology|November 22, 2025
Success of restoration strategies in preventing extirpation of 2 critically endangered coral speciesErinn M Muller, Mark C Ladd, Richard Karp, et al.
Nucleic Acids Research|May 12, 2018
Novel diagnostic tool for prediction of variant spliceogenicity derived from a set of 395 combined in silico/in vitro studies: an international collaborative effortRaphaël Leman, Pascaline Gaildrat, Gérald Le Gac, et al.
Human Mutation|October 23, 2022
SPiP: Splicing Prediction Pipeline, a machine learning tool for massive detection of exonic and intronic variant effects on mRNA splicingRaphaël Leman, Béatrice Parfait, Dominique Vidaud, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|May 16, 2019
Whole-genome sequencing reveals clinically relevant insights into the aetiology of familial breast cancersK Nones, J Johnson, F Newell, et al.
Human Mutation|June 19, 2019
The spectrum of BRCA1 and BRCA2 pathogenic sequence variants in Middle Eastern, North African, and South European countriesYael Laitman, Tara M Friebel, Drakoulis Yannoukakos, et al.
European Journal of Human Genetics : EJHG|February 2, 2017
Evaluation of copy-number variants as modifiers of breast and ovarian cancer risk for BRCA1 pathogenic variant carriersLogan C Walker, Louise Marquart, John F Pearson, et al.
ACS Medicinal Chemistry Letters|September 24, 2015
Oxopyrido[2,3-d]pyrimidines as Covalent L858R/T790M Mutant Selective Epidermal Growth Factor Receptor (EGFR) InhibitorsRyan P Wurz, Liping H Pettus, Kate Ashton, et al.
Pageof 87

Showing results (811-820 of 865) with videos related to

Sort By:
Pageof 87
Cancer Medicine|August 28, 2024
Atypical cancer risk profile in carriers of Italian founder BRCA1 variant p.His1673del: Implications for classification and clinical managementGiovanni Innella, Cristina Fortuno, Laura Caleca, et al.
NPJ Breast Cancer|September 30, 2025
Polygenic risk score for breast cancer risk prediction in Asian BRCA1 and BRCA2 pathogenic variants carriersMei-Chee Tai, Joe Dennis, Sue K Park, et al.
Human Mutation|July 12, 2019
Assessment of blind predictions of the clinical significance of BRCA1 and BRCA2 variantsMelissa S Cline, Giulia Babbi, Sandra Bonache, et al.
Conservation Biology : the Journal of the Society for Conservation Biology|November 22, 2025
Success of restoration strategies in preventing extirpation of 2 critically endangered coral speciesErinn M Muller, Mark C Ladd, Richard Karp, et al.
Nucleic Acids Research|May 12, 2018
Novel diagnostic tool for prediction of variant spliceogenicity derived from a set of 395 combined in silico/in vitro studies: an international collaborative effortRaphaël Leman, Pascaline Gaildrat, Gérald Le Gac, et al.
Human Mutation|October 23, 2022
SPiP: Splicing Prediction Pipeline, a machine learning tool for massive detection of exonic and intronic variant effects on mRNA splicingRaphaël Leman, Béatrice Parfait, Dominique Vidaud, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|May 16, 2019
Whole-genome sequencing reveals clinically relevant insights into the aetiology of familial breast cancersK Nones, J Johnson, F Newell, et al.
Human Mutation|June 19, 2019
The spectrum of BRCA1 and BRCA2 pathogenic sequence variants in Middle Eastern, North African, and South European countriesYael Laitman, Tara M Friebel, Drakoulis Yannoukakos, et al.
European Journal of Human Genetics : EJHG|February 2, 2017
Evaluation of copy-number variants as modifiers of breast and ovarian cancer risk for BRCA1 pathogenic variant carriersLogan C Walker, Louise Marquart, John F Pearson, et al.
ACS Medicinal Chemistry Letters|September 24, 2015
Oxopyrido[2,3-d]pyrimidines as Covalent L858R/T790M Mutant Selective Epidermal Growth Factor Receptor (EGFR) InhibitorsRyan P Wurz, Liping H Pettus, Kate Ashton, et al.
Pageof 87